• Citer

Impact of pegylated interferon and ribavirin on morbidity and mortality in patients with chronic hepatitis C and normal aminotransferases in France.

par Deuffic-Burban, Sylvie;Babany, Gérard;Lonjon-Domanec, Isabelle;Deltenre, Pierre ;Canva-Delcambre, Valérie;Dharancy, Sébastien;Louvet, Alexandre;Roudot-Thoraval, Françoise;Mathurin, Philippe
Référence Hepatology, 50, 5, page (1351-1359)
Publication Publié, 2009-11

Article révisé par les pairs

• Détails
• Contenu

Titre:	Impact of pegylated interferon and ribavirin on morbidity and mortality in patients with chronic hepatitis C and normal aminotransferases in France.
Auteur:	Deuffic-Burban, Sylvie; Babany, Gérard; Lonjon-Domanec, Isabelle; Deltenre, Pierre; Canva-Delcambre, Valérie; Dharancy, Sébastien; Louvet, Alexandre; Roudot-Thoraval, Françoise; Mathurin, Philippe
Informations sur la publication:	Hepatology, 50, 5, page (1351-1359)
Statut de publication:	Publié, 2009-11
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adolescent
	Adult
	Aged
	Alanine Transaminase -- blood
	Antiviral Agents -- therapeutic use
	Child
	Child, Preschool
	Disease Progression
	Drug Therapy, Combination
	Female
	France
	Hepatitis C, Chronic -- blood -- drug therapy -- mortality
	Humans
	Infant
	Infant, Newborn
	Interferon alpha-2
	Interferon-alpha -- therapeutic use
	Male
	Middle Aged
	Patient Selection
	Polyethylene Glycols -- therapeutic use
	Recombinant Proteins
	Retrospective Studies
	Ribavirin -- therapeutic use
	Sensitivity and Specificity
	Young Adult
Langue:	Anglais
Identificateurs:	urn:issn:0270-9139
	info:doi/10.1002/hep.23159
	info:pmid/19676130